These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 6721467)
41. A multi-centre general practice comparison of a fixed-dose combination of pivmecillinam plus pivampicillin with amoxycillin in respiratory tract infections. Shenderey K; Marsh BT; Talbot DJ Pharmatherapeutica; 1985; 4(5):300-5. PubMed ID: 4070323 [TBL] [Abstract][Full Text] [Related]
42. Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children. McLinn SE; Moskal M; Goldfarb J; Bodor F; Aronovitz G; Schwartz R; Self P; Ossi MJ Antimicrob Agents Chemother; 1994 Feb; 38(2):315-8. PubMed ID: 8192458 [TBL] [Abstract][Full Text] [Related]
43. Double-blind comparison of pivmecillinam plus pivampicillin ('Miraxid') with pivampicillin alone in chronic bronchitis: a Danish multi-centre study. Bukh N Pharmatherapeutica; 1983; 3(6):422-8. PubMed ID: 6312461 [TBL] [Abstract][Full Text] [Related]
44. Pivmecillinam in the treatment of therapy resistant urinary tract infections. A comparison with pivmecillinam, pivampicillin and their combination. Andersen BT; Joergensen M; Lorenzen J Infection; 1980; 8(1):27-31. PubMed ID: 6246005 [TBL] [Abstract][Full Text] [Related]
45. Cefuroxime axetil: an updated review of its use in the management of bacterial infections. Scott LJ; Ormrod D; Goa KL Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834 [TBL] [Abstract][Full Text] [Related]
46. Pivmecillinam plus pivampicillin in urinary tract infections: a randomized, open comparison with co-trimoxazole in hospitalized patients. Ravn TJ Pharmatherapeutica; 1981; 2(9):581-6. PubMed ID: 6267617 [TBL] [Abstract][Full Text] [Related]
47. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. File TM; Segreti J; Dunbar L; Player R; Kohler R; Williams RR; Kojak C; Rubin A Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395 [TBL] [Abstract][Full Text] [Related]
48. [Various characteristics of the pharmacokinetics of ampicillin, kanamycin and cefuroxime in puerperants with endometritis]. Amiraslanova LA; Emel'ianova AI; Fursova SA; Rukhadze TG Akush Ginekol (Mosk); 1985 Oct; (10):14-7. PubMed ID: 2934996 [No Abstract] [Full Text] [Related]
49. A comparison of pivmecillinam/pivampicillin and co-trimoxazole in hospitalized patients with acute exacerbations of chronic bronchitis. Lal S; McGhie D; Kerfoot P J Antimicrob Chemother; 1984 Aug; 14(2):179-84. PubMed ID: 6334071 [TBL] [Abstract][Full Text] [Related]
50. Bioavailability of cefuroxime axetil formulations. Donn KH; James NC; Powell JR J Pharm Sci; 1994 Jun; 83(6):842-4. PubMed ID: 9120818 [TBL] [Abstract][Full Text] [Related]
51. General practice studies with combined pivampicillin/pivmecillinam (Miraxid). Moorhouse EC; Hickey MP; O'Hanrahan MT; Clarke PC Ir Med J; 1985 Nov; 78(11):314-7. PubMed ID: 3878343 [No Abstract] [Full Text] [Related]
52. Treatment of Salmonella carriers with pivmecillinam alone or in combination with pivampicillin: experience with three patients. Bruun JN; Digranes A; Bøe J; Maeland A Scand J Infect Dis; 1983; 15(1):21-4. PubMed ID: 6302830 [TBL] [Abstract][Full Text] [Related]
54. A multi-centre general practice clinical evaluation of pivmecillinam plus pivampicillin ('Miraxid') and co-trimoxazole ('Septrin') in respiratory tract infections. Wallace RB; Marsh BT; Talbot DJ Curr Med Res Opin; 1985; 9(10):659-65. PubMed ID: 3907987 [TBL] [Abstract][Full Text] [Related]
55. Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up. Brumfitt W; Hamilton-Miller JM; Smith GW Antimicrob Agents Chemother; 1987 Sep; 31(9):1442-3. PubMed ID: 3674851 [TBL] [Abstract][Full Text] [Related]
56. Randomised trial of pivampicillin plus pivmecillinam vs. pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae. Johansen HK; Børch K; Espersen F; Koch C; Høiby N Curr Med Res Opin; 1999; 15(4):300-9. PubMed ID: 10640263 [TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime. Ruiz-Carretero P; Merino-Sanjuán M; Nácher A; Casabó VG Eur J Pharm Sci; 2004 Feb; 21(2-3):217-23. PubMed ID: 14757493 [TBL] [Abstract][Full Text] [Related]